Data / Form D filings / Pearl Diagnostics, Inc.
Pearl Diagnostics, Inc.: Form D filings
Pearl Diagnostics, Inc., a biotechnology company in Baltimore, MD, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on April 21, 2026, reports $11.2 million sold of a $11.2 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1812 ASHLAND AVENUE SUITE G32, Baltimore, MD, 21205
- Phone
- (410) 614-0300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1922830
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | New notice | $11,150,000 | $11,150,000 | 21 | Mar 19, 2026 | sec.gov | |
| Jun 17, 2022 | New notice | $3,525,000 | $3,525,000 | 11 | Feb 23, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kieren Marr | Executive Officer, Director | |
| Brad Spellberg | Director | |
| John Cammack | Director | |
| Eric Gornstein | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pearl Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.